Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 4 2Phase 2/3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Pain, Postoperative 4Pain 3Neoplasms 3Breast Neoplasms 2Urinary Bladder Neoplasms 1Pneumonia 1Patient Satisfaction 1Paget Disease, Extramammary 1Operable Breast Cancer 1Myofascial Pain Syndromes 1Lymphoma, Follicular 1Lung Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Chronic Pain 1Cancer Pain 1Agnosia 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Prednisone 9Pemetrexed 9Epoetin Alfa 9venetoclax 8atezolizumab 8Fentanyl 8Drug Therapy 8Doxorubicin 8Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Lidocaine × Clear all
NCT04703803 2023-04-25

Efficacy of Myofascial Pain Syndrome Treatment in Patients With Cancer in Palliative Care

University of Sao Paulo

Phase 3 Completed
30 enrolled

Cancer Pain, Myofascial Pain Syndromes, Neoplasms

NCT02137954 2015-08-28

LIDOSP

Assistance Publique Hopitaux De Marseille

Phase 3 Unknown
200 enrolled

Neoplasms, Pain

NCT00181012 2007-09-19

Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Unknown
100 enrolled

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡